← Go back Jan 01, 2022
Good morning. There's no shortage of news for Unilever at the moment. After its disastrous £50bn move on GSK's consumer arm which was firmly rebuffed by the pharmaceutical giant and lambasted by sh…
Read more: Telegraph.co.uk
